SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
4.470
+0.210 (4.93%)
Apr 16, 2025, 10:17 AM EDT - Market open

Company Description

SBC Medical Group Holdings Incorporated, together with its subsidiaries, engages in the provision of management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally.

The company provides advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design services for franchisee clinics; and medical consumables procurement services.

It also offers medical equipment; cosmetic products to franchisee clinics for resale to clinic customers; and IT software solutions.

In addition, the company provides surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods.

Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.

SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings logo
Country United States
Founded 2000
Industry Consulting Services
Sector Industrials
Employees 863
CEO Yoshiyuki Aikawa

Contact Details

Address:
200 Spectrum Center Drive, Suite 300
Irvine, California 92618
United States
Phone 949-593-0250
Website sbc-holdings.com

Stock Details

Ticker Symbol SBC
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001930313
ISIN Number US73245B1070
Employer ID 88-1263511
SIC Code 8011

Key Executives

Name Position
Yuji Katayose Marketing Director
Yoshimune Tanaka Property Acquisition Director

Latest SEC Filings

Date Type Title
Apr 2, 2025 8-K Current Report
Apr 1, 2025 424B3 Prospectus
Apr 1, 2025 POS EX Filing
Mar 28, 2025 10-K Annual Report
Mar 28, 2025 8-K Current Report
Feb 18, 2025 8-K Current Report
Dec 20, 2024 8-K Current Report
Nov 14, 2024 424B3 Prospectus
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 8-K Current Report